BridgeBio Pharma (BBIO) PT Raised to $95 at Cantor Fitzgerald
Tweet
Share
E-mailGet Alerts BBIO Hot Sheet
Price: $79.86 -1.66%
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Cantor Fitzgerald analyst Josh Schimmer raised the price target on BridgeBio Pharma (NASDAQ: BBIO) to $95.00 (from $70.00) while maintaining a Overweight rating.
You May Also Be Interested In
- BridgeBio Pharma (BBIO) PT Raised to $106 at Canaccord
- Va Tech Wabag Ltd. (VATW:IN) PT Raised to INR2,410 at ICICI Securities
- KKR prices secondary offering of 5 million BridgeBio shares
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
